Oculus Innovative Sciences Reports Second Quarter FY 2010: 60% Reduction in Operating Expenses and 16% Increase in Product Revenue (37% in Local Currency) Nov 5, 2009
Oculus Innovative Sciences Announces Fiscal Second Quarter 2010 Financial Results and Corporate Update Release and Conference Call Oct 22, 2009
Oculus Innovative Sciences Rolls Out Microcyn(R) HydroGel Skin and Wound Care Products for Both U.S. Healthcare Professionals and Consumers Sep 28, 2009
Oculus Innovative Sciences Announces New Partnership Agreement with V&M Industries, Inc. for Microcyn(R)-Based OTC Human Wound Care Products Sep 16, 2009
Oculus Innovative Sciences Receives Medicare HCPCS Code for Reimbursement of Microcyn(R) Skin & Wound HydroGel Sep 10, 2009
Oculus Innovative Sciences Announces Microcyn(R) Skin and Wound Cleanser with Preservatives Now Commercially Available in the United States Aug 18, 2009
Oculus Innovative Sciences Announces Fiscal First Quarter Financial Results and Corporate Update Release and Conference Call Jul 29, 2009